Literature DB >> 16432602

Antimony-induced cerebellar ataxia.

Eltahir Awad G Khalil1, Ammar E Ahmed, Ahmed M Musa, Muna H Hussein.   

Abstract

Visceral leishmaniasis VL, caused by Leishmania donovani is endemic over several parts of Sudan. The disease is fatal if not treated. Although sodium stibogluconate Pentostam, a pentavalent antimonial is not free from toxicity, it has been in use for treatment of VL for the last 50 years. Like other infectious diseases, neurological manifestations of VL and sodium stibogluconate have been documented. In this report, we present 2 cases of cerebellar ataxia most likely induced by Pentostam, and explain the probable cause.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432602

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  6 in total

1.  Treatment of visceral leishmaniasis in children in the Central-West Region of Brazil.

Authors:  Y M Brustoloni; R V Cunha; L Z Cônsolo; A L L Oliveira; M E C Dorval; E T Oshiro
Journal:  Infection       Date:  2010-05-28       Impact factor: 3.553

2.  Antimony and sleep-related disorders: NHANES 2005-2008.

Authors:  Franco Scinicariello; Melanie C Buser; Aliya G Feroe; Roberta Attanasio
Journal:  Environ Res       Date:  2017-03-28       Impact factor: 6.498

Review 3.  Liposomal drug delivery systems for the treatment of leishmaniasis.

Authors:  Felipe Francisco Tuon; Leticia Ramos Dantas; Regina Maia de Souza; Victoria Stadler Tasca Ribeiro; Valdir Sabbaga Amato
Journal:  Parasitol Res       Date:  2022-09-16       Impact factor: 2.383

4.  Heavy Metals' Effect on Susceptibility to Attention-Deficit/Hyperactivity Disorder: Implication of Lead, Cadmium, and Antimony.

Authors:  Min-Jing Lee; Miao-Chun Chou; Wen-Jiun Chou; Chien-Wei Huang; Ho-Chang Kuo; Sheng-Yu Lee; Liang-Jen Wang
Journal:  Int J Environ Res Public Health       Date:  2018-06-10       Impact factor: 3.390

5.  Treatment-based strategy for the management of post-kala-azar dermal leishmaniasis patients in the Sudan.

Authors:  A M Musa; E A G Khalil; B M Younis; M E E Elfaki; M Y Elamin; A O A Adam; H A A Mohamed; M M M Dafalla; A A Abuzaid; A M El-Hassan
Journal:  J Trop Med       Date:  2013-04-15

6.  Neurological toxicity due to antimonial treatment for refractory visceral leishmaniasis.

Authors:  Marta Maristany Bosch; Guillermo Cuervo; Elisabeth Matas Martín; Misericordia Veciana de Las Heras; Jordi Pedro Pérez; Sergio Martínez Yélamos; Nuria Sabé Fernández
Journal:  Clin Neurophysiol Pract       Date:  2021-04-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.